1 |
0.5% marcaine |
- |
- |
- |
- |
070 [1] 70 💬 |
2 |
0.9% saline |
- |
- |
- |
- |
070 [1] 70 💬 |
3 |
0002-8971 |
- |
- |
- |
- |
070 [1] 70 💬 |
4 |
1mg/kg/hr txa intravenous infusion till the last suture |
- |
- |
- |
- |
070 [1] 70 💬 |
5 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
6 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
7 |
Adjunctive analgesics |
- |
- |
- |
- |
070 [1] 70 💬 |
8 |
Adjunctive anti-depressants |
- |
- |
- |
- |
070 [1] 70 💬 |
9 |
Ak1320 ms |
- |
- |
- |
- |
070 [1] 70 💬 |
10 |
Allogen-li |
- |
- |
- |
- |
070 [1] 70 💬 |
11 |
Alprostadil |
Alprostadil |
[2] D00180 D00180, D02705 D02705 💬 |
PTGER1 [1] PTGER1 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 [2] 51, 70 💬 |
12 |
Amino acids |
Amino acids |
- |
- |
- |
070 [3] 70, 240, 298 💬 |
13 |
Aminocaproic acid |
Aminocaproic acid |
[1] D00160 D00160 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 [1] 70 💬 |
14 |
Amniotic fluid allograft |
- |
- |
- |
- |
070 [1] 70 💬 |
15 |
Apple |
Apple |
- |
- |
- |
070 [1] 70 💬 |
16 |
Bilateral transforaminal epidural steroid injections |
- |
- |
- |
- |
070 [1] 70 💬 |
17 |
Bone marrow concentrate |
- |
- |
- |
- |
070 [1] 70 💬 |
18 |
Botulinum toxin type a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [10] 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
19 |
Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
070 [1] 70 💬 |
20 |
Bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [8] 46, 51, 53, 70, 96, 168, 226, 298 💬 |
21 |
Bupivacaïne hcl 0,125% / sufentanil 50 µg flacon à 50 ml |
Sufentanil |
[2] D00845 D00845, D05938 D05938 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
22 |
Buprenorphine |
Buprenorphine |
[2] D00836 D00836, D07132 D07132 💬 |
OPRK1 [2] OPRK1, OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [2] 46, 70 💬 |
23 |
Caudal epidural injection |
- |
- |
- |
- |
070 [1] 70 💬 |
24 |
Caudal epidural injection with celestone |
- |
- |
- |
- |
070 [1] 70 💬 |
25 |
Caudal epidural injection with depomedrol |
- |
- |
- |
- |
070 [1] 70 💬 |
26 |
Caudal epidural injection with generic celestone |
- |
- |
- |
- |
070 [1] 70 💬 |
27 |
Celebrex 200mg capsule |
- |
- |
- |
- |
070 [1] 70 💬 |
28 |
Celecoxib |
Celecoxib |
[1] D00567 D00567 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 [9] 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
29 |
Cilostazol |
Cilostazol |
[1] D01896 D01896 💬 |
PDE3A [3] PDE3A, PDE3B, TBXA2R 💬 |
Apelin signaling pathway [14] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 70 💬 |
30 |
Co |
- |
- |
- |
- |
006 [5] 6 , 13, 53, 70, 85 💬 |
31 |
Combination product: goldic serum |
- |
- |
- |
- |
070 [1] 70 💬 |
32 |
Control group |
- |
- |
- |
- |
002 [3] 2 , 46, 70 💬 |
33 |
Creatinine |
Creatinine |
[1] D03600 D03600 💬 |
- |
- |
002 [4] 2 , 46, 60, 70 💬 |
34 |
Darvocet |
- |
- |
- |
- |
070 [1] 70 💬 |
35 |
Decadron phosphate, injectable |
Phosphate ion |
- |
- |
- |
070 [1] 70 💬 |
36 |
Deksmedetomidiini |
- |
- |
- |
- |
070 [1] 70 💬 |
37 |
Demineralized bone matrix |
- |
- |
- |
- |
070 [1] 70 💬 |
38 |
Depomedrol |
- |
- |
- |
- |
070 [1] 70 💬 |
39 |
Device: apple watch and app |
Apple |
- |
- |
- |
070 [1] 70 💬 |
40 |
Device: bioactive glass-ceramic spacer |
- |
- |
- |
- |
070 [1] 70 💬 |
41 |
Device: cervical orthosis (co) |
- |
- |
- |
- |
070 [1] 70 💬 |
42 |
Device: interbody cage (peek) |
- |
- |
- |
- |
070 [1] 70 💬 |
43 |
Device: interbody cage (titanium) |
Titanium |
- |
- |
- |
070 [1] 70 💬 |
44 |
Device: mastergraft granules |
- |
- |
- |
- |
070 [1] 70 💬 |
45 |
Device: mild® (minimally invasive lumbar decompression) |
- |
- |
- |
- |
070 [1] 70 💬 |
46 |
Device: mri |
- |
- |
- |
- |
070 [3] 70, 85, 278 💬 |
47 |
Device: no orthosis |
- |
- |
- |
- |
070 [1] 70 💬 |
48 |
Device: philips intelivue mp70 monitor |
Methamidophos |
- |
- |
- |
070 [1] 70 💬 |
49 |
Device: pleth variability index (pvi) |
- |
- |
- |
- |
070 [1] 70 💬 |
50 |
Device: therm-apptm th, thermographic camera |
- |
- |
- |
- |
070 [1] 70 💬 |
51 |
Device: titanium cage |
Titanium |
- |
- |
- |
070 [1] 70 💬 |
52 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
53 |
Dexamethasone sodium phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [3] 65, 70, 96 💬 |
54 |
Dexdor |
- |
- |
- |
- |
002 [4] 2 , 4 , 6 , 70 💬 |
55 |
Dexmedetomidine |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [12] 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
56 |
Dexmedetomidine group |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
57 |
Dexmedetomidine hydrochloride |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
58 |
Dexmedetomidine with ropivacaine |
Dexmedetomidine |
[4] D00514 D00514, D01205 D01205, D04048 D04048, D08490 D08490 💬 |
ADRA2A [8] ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
59 |
Dextrose |
Dextrose, unspecified form |
- |
- |
- |
056 [4] 56, 60, 65, 70 💬 |
60 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
61 |
Eaca |
Aminocaproic acid |
[1] D00160 D00160 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 [1] 70 💬 |
62 |
Epidural injection |
- |
- |
- |
- |
070 [1] 70 💬 |
63 |
Epidural local anesthetic injection |
- |
- |
- |
- |
070 [1] 70 💬 |
64 |
Epidural steroid injection |
- |
- |
- |
- |
070 [1] 70 💬 |
65 |
Epsilon-aminocaproic acid (eaca) |
Aminocaproic acid |
[1] D00160 D00160 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 [1] 70 💬 |
66 |
Erector spinae plane block (group e) |
- |
- |
- |
- |
070 [1] 70 💬 |
67 |
Erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [9] 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
68 |
Esketamine |
Esketamine |
[1] D07283 D07283 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [3] 2 , 4 , 70 💬 |
69 |
Esketamine hydrochloride |
Esketamine |
[1] D07283 D07283 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
070 [1] 70 💬 |
70 |
Fentanyl |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [4] 46, 70, 215, 231 💬 |
71 |
Forsteo |
- |
- |
- |
- |
070 [3] 70, 235, 274 💬 |
72 |
Forteo |
- |
- |
- |
- |
070 [1] 70 💬 |
73 |
Gabapentin |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [5] 6 , 13, 19, 70, 298 💬 |
74 |
Heparin |
Heparin |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
060 [11] 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 💬 |
75 |
Herbal medicine |
- |
- |
- |
- |
070 [1] 70 💬 |
76 |
Hyaluronic acid |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
046 [5] 46, 53, 70, 226, 231 💬 |
77 |
Hydromorphone |
Hydromorphone |
[2] D00839 D00839, D08047 D08047 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
78 |
I-factor |
- |
- |
- |
- |
070 [1] 70 💬 |
79 |
Kenalog injectable product |
- |
- |
- |
- |
070 [1] 70 💬 |
80 |
Ketamine |
Ketamine |
[2] D00711 D00711, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [5] 13, 70, 113, 156, 215 💬 |
81 |
Ketanest |
- |
- |
- |
- |
002 [3] 2 , 4 , 70 💬 |
82 |
Ketanest-s |
- |
- |
- |
- |
002 [3] 2 , 4 , 70 💬 |
83 |
Ketorolac |
Ketorolac |
[2] D00813 D00813, D08104 D08104 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
070 [2] 70, 226 💬 |
84 |
Limaprost |
Limaprost |
[1] D02722 D02722 💬 |
PTGER1 [1] PTGER1 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
070 [1] 70 💬 |
85 |
Liposomal bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [3] 51, 70, 96 💬 |
86 |
Lumbar interbody fusion with autograft |
- |
- |
- |
- |
070 [1] 70 💬 |
87 |
Lumbar interbody fusion with neofuse |
- |
- |
- |
- |
070 [1] 70 💬 |
88 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
89 |
Magnesium with ropivacaine |
Magnesium |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 [1] 70 💬 |
90 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
91 |
Mirogabalin |
Mirogabalin |
[1] D11203 D11203 💬 |
CACNA2D1 [2] CACNA2D1, CACNA2D2 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 [1] 70 💬 |
92 |
Misoprostol |
Misoprostol |
[1] D00419 D00419 💬 |
PTGER2 [3] PTGER2, PTGER3, PTGER4 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway |
046 [3] 46, 70, 271 💬 |
93 |
Modal |
- |
- |
- |
- |
002 [5] 2 , 6 , 17, 46, 70 💬 |
94 |
Modified-thoracolumbar interfascial plane block |
- |
- |
- |
- |
070 [1] 70 💬 |
95 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
96 |
Morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [5] 36, 46, 70, 85, 86 💬 |
97 |
Morphine pca |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
98 |
Multi-modal pain management [acetaminophen + gabapentin] |
Acetaminophen |
[2] D00217 D00217, D00332 D00332 💬 |
CACNA2D1 [7] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [31] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway |
070 [1] 70 💬 |
99 |
Multi-modal pain management [fentanyl] |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
100 |
Multi-modal pain management [intravenous ketamine] |
Ketamine |
[2] D00711 D00711, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
070 [1] 70 💬 |
101 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
102 |
Neofuse |
- |
- |
- |
- |
070 [1] 70 💬 |
103 |
Nicardipine |
Nicardipine |
[2] D00617 D00617, D08270 D08270 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
070 [2] 70, 86 💬 |
104 |
Normal saline |
- |
- |
- |
- |
006 [16] 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
105 |
Ns-304 |
- |
- |
- |
- |
070 [3] 70, 86, 88 💬 |
106 |
Ns-304 placebo |
- |
- |
- |
- |
070 [2] 70, 88 💬 |
107 |
Nsaids |
- |
- |
- |
- |
046 [4] 46, 70, 107, 271 💬 |
108 |
Nucel |
- |
- |
- |
- |
070 [1] 70 💬 |
109 |
Oksikodoni |
- |
- |
- |
- |
070 [1] 70 💬 |
110 |
Opana |
- |
- |
- |
- |
070 [1] 70 💬 |
111 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
112 |
Other: conventional pca mode |
- |
- |
- |
- |
070 [1] 70 💬 |
113 |
Other: epiduroscopy |
- |
- |
- |
- |
070 [1] 70 💬 |
114 |
Other: group exercise: community setting |
- |
- |
- |
- |
070 [1] 70 💬 |
115 |
Other: individualized exercises: clinical setting |
- |
- |
- |
- |
070 [1] 70 💬 |
116 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 [1] 70 💬 |
117 |
Other: no intervention |
- |
- |
- |
- |
070 [1] 70 💬 |
118 |
Other: optimizing basal infusion (b.i) |
- |
- |
- |
- |
070 [1] 70 💬 |
119 |
Other: other intervention(s) |
- |
- |
- |
- |
070 [1] 70 💬 |
120 |
Other: physical therapy |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
121 |
Oxanest |
- |
- |
- |
- |
070 [1] 70 💬 |
122 |
Oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [7] 6 , 13, 46, 70, 226, 231, 298 💬 |
123 |
Oxycodone hydrochloride |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [4] 6 , 70, 226, 298 💬 |
124 |
Oxycodone orion |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
125 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
126 |
Parathyroid hormone |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [2] 70, 235 💬 |
127 |
Pca |
- |
- |
- |
- |
046 [2] 46, 70 💬 |
128 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
129 |
Plf with neofuse |
- |
- |
- |
- |
070 [1] 70 💬 |
130 |
Polydeoxyribonucleotides |
- |
- |
- |
- |
051 [2] 51, 70 💬 |
131 |
Predinose oral |
- |
- |
- |
- |
070 [1] 70 💬 |
132 |
Pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 [5] 13, 36, 46, 70, 298 💬 |
133 |
Pregabalin 75mg |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 [1] 70 💬 |
134 |
Procedure: acupuncture |
- |
- |
- |
- |
046 [2] 46, 70 💬 |
135 |
Procedure: allograft |
- |
- |
- |
- |
070 [1] 70 💬 |
136 |
Procedure: bee venom pharmacopuncture |
- |
- |
- |
- |
070 [1] 70 💬 |
137 |
Procedure: chuna manipulation |
- |
- |
- |
- |
070 [1] 70 💬 |
138 |
Procedure: chuna manual medicine |
- |
- |
- |
- |
070 [1] 70 💬 |
139 |
Procedure: cupping |
- |
- |
- |
- |
070 [1] 70 💬 |
140 |
Procedure: electroacupuncture |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
141 |
Procedure: epidural local anesthetic injection |
- |
- |
- |
- |
070 [1] 70 💬 |
142 |
Procedure: epidural steroid (dexamethasone) injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
143 |
Procedure: epidural steroid injection |
- |
- |
- |
- |
070 [1] 70 💬 |
144 |
Procedure: epidural steroid with local anesthetic injection |
- |
- |
- |
- |
070 [1] 70 💬 |
145 |
Procedure: lumbar epidural injection |
- |
- |
- |
- |
070 [1] 70 💬 |
146 |
Procedure: lumbar interlaminar epidural steroid injection |
- |
- |
- |
- |
070 [1] 70 💬 |
147 |
Procedure: manual therapy |
- |
- |
- |
- |
070 [1] 70 💬 |
148 |
Procedure: mild procedure |
- |
- |
- |
- |
070 [1] 70 💬 |
149 |
Procedure: other intervention(s) |
- |
- |
- |
- |
070 [1] 70 💬 |
150 |
Procedure: percutaneous lumbar decompression |
- |
- |
- |
- |
070 [1] 70 💬 |
151 |
Procedure: pharmacopuncture |
- |
- |
- |
- |
070 [1] 70 💬 |
152 |
Procedure: plf with autograft |
- |
- |
- |
- |
070 [1] 70 💬 |
153 |
Procedure: posterolateral spinal fusion with instrumentation |
- |
- |
- |
- |
070 [1] 70 💬 |
154 |
Prolotherapy solution of 20% dextrose |
Dextrose, unspecified form |
- |
- |
- |
070 [1] 70 💬 |
155 |
Remifentanil |
Remifentanil |
[2] D01177 D01177, D08473 D08473 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
006 [2] 6 , 70 💬 |
156 |
Rhpth |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [3] 70, 235, 326 💬 |
157 |
Rhpth (1-34) |
Parathyroid hormone |
[1] D05364 D05364 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [1] 70 💬 |
158 |
Ropivacaine |
Ropivacaine |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
036 [3] 36, 46, 70 💬 |
159 |
Ropivacaine plus normal saline |
Ropivacaine |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 [1] 70 💬 |
160 |
S-ketamine |
Esketamine |
[3] D00711 D00711, D07283 D07283, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
070 [1] 70 💬 |
161 |
S-ketamine & midazolam |
Esketamine |
[6] D00550 D00550, D00696 D00696, D00711 D00711, D05028 D05028, D07283 D07283, D08098 D08098 💬 |
GABRA1 [21] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [25] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
070 [1] 70 💬 |
162 |
Selexipag |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [5] 51, 70, 84, 86, 88 💬 |
163 |
Standard analgesia use [fentanyl] |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
164 |
Standard analgesia use [hydromorphone] |
Hydromorphone |
[2] D00839 D00839, D08047 D08047 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
165 |
Standard analgesia use [oxygen] |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
070 [1] 70 💬 |
166 |
Standard analgesia use [volatile anesthesia] |
- |
- |
- |
- |
070 [1] 70 💬 |
167 |
Steroid injections |
- |
- |
- |
- |
070 [1] 70 💬 |
168 |
Sufentanil |
Sufentanil |
[2] D00845 D00845, D05938 D05938 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [2] 70, 280 💬 |
169 |
Sugar pill |
- |
- |
- |
- |
005 [8] 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
170 |
Teicoplanin |
Teicoplanin |
[1] D02142 D02142 💬 |
- |
- |
070 [2] 70, 299 💬 |
171 |
Teriparatide |
Teriparatide |
[1] D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
046 [6] 46, 68, 70, 71, 235, 274 💬 |
172 |
Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34) |
Parathyroid hormone |
[2] D05364 D05364, D06078 D06078 💬 |
PTH1R [2] PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 [1] 70 💬 |
173 |
Titanium |
Titanium |
- |
- |
- |
069 [2] 69, 70 💬 |
174 |
Tramadol |
Tramadol |
[2] D01355 D01355, D08623 D08623 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [5] 46, 70, 78, 226, 271 💬 |
175 |
Tramadol with ropivacaine |
Ropivacaine |
[4] D01355 D01355, D04048 D04048, D08490 D08490, D08623 D08623 💬 |
OPRM1 [6] OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction |
070 [1] 70 💬 |
176 |
Tranexamic acid |
Tranexamic acid |
[1] D01136 D01136 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 [5] 46, 70, 215, 227, 288 💬 |
177 |
Tranexamic acid 100 mg/ml |
Tranexamic acid |
[1] D01136 D01136 💬 |
PLG [1] PLG 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 [1] 70 💬 |
178 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
[3] D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 [6] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
179 |
Transforaminal epidural injection |
- |
- |
- |
- |
070 [1] 70 💬 |
180 |
Triamcinolone |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [8] 35, 46, 56, 70, 90, 96, 226, 298 💬 |
181 |
Triamcinolone acetonide and normal saline solution |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
182 |
Tylenol |
- |
- |
- |
- |
070 [1] 70 💬 |
183 |
Vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
046 [7] 46, 70, 94, 96, 97, 296, 299 💬 |
184 |
Vivigen cellular bone matrix |
- |
- |
- |
- |
070 [1] 70 💬 |
185 |
With u-vanco (vancomycin hydrochloride) |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
070 [1] 70 💬 |
186 |
Without u-vanco (vancomycin hydrochloride) |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
070 [1] 70 💬 |
187 |
Wound topically irrigated with 500mg txa |
- |
- |
- |
- |
070 [1] 70 💬 |
188 |
Xylocaine |
- |
- |
- |
- |
070 [1] 70 💬 |